• About Us
  • Contact Us
  • Patient Registration
  • Search
    RTOGSearch
  • × Close
  • Clinical Trials

      Clinical Trials

      1. Data Monitoring Committee
      2. Legacy Studies
      3. Publications
      4. Foundation Studies
  • Partners

      Partners

    • RTQA & Physics

        RTQA & Physics

        1. Core Services
        2. Quality Assurance
        3. Data Submission
    • Resources

        Resources

        1. RTOGF Videos
        2. VisionTree Training
    • Menu
    1. Home
    2. Sitemap
    • Clinical Trials
      • Data Monitoring Committee
      • Legacy Studies
      • Publications
      • Foundation Studies
        • RTOG 3501
        • RTOG 3502
        • RTOG 3503
        • RTOG 3504
        • RTOG 3505
        • RTOG 3506
        • RTOG 3507
        • RTOG 3508
        • RTOG 3509/3510
        • RTOG 3515
        • ACR 3518
        • RTOG Foundation Study 3523
        • RTOG 3521
    • Partners
    • RTQA & Physics
      • Core Services
      • Quality Assurance
      • Data Submission
    • Resources
      • RTOGF Videos
      • VisionTree Training
    • NRG Oncology Abstract Considered “Best of ASCO” for 2024 Shows Difference in Outcomes for Node-Negative Versus Node-Positive Pancreatic Cancer Patients when Adding Chemoradiation to Systemic Therapy
    • Test-the-page
    RTOG Headquarters

    50 South 16th Street, Suite 2800
    Philadelphia, PA 19102 | 215-574-3150

    RTOG Facebook logo
         
    RTOG Instagram logo
         
    RTOG LinkedIn logo
         
    RTOG Twitter logo
         
    RTOG YouTube logo
         

    Holiday Closures | Employee Directory   

    American College of Radiology logo

    Privacy Statement | Copyright (c) 2025 RTOG

    RTOG is a participant in National Cancer Institute research through NRG Oncology.